Symetryx Corp - 10%+ Owner at NeuBase Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
NBSE
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Symetryx Corp since 11/12/2023

Holdings reported by Symetryx Corp for NeuBase Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, par value $0.0001 192K $370K $1.92 Sep 18, 2023 Direct
Common Stock, Par Value $0.0001 per Share 0 $1.19 Sep 18, 2023 Direct

Transactions reported by Symetryx Corp for NeuBase Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.